MX2009008488A - Forma estabilizadora de dosificacion oral de picoplatino. - Google Patents
Forma estabilizadora de dosificacion oral de picoplatino.Info
- Publication number
- MX2009008488A MX2009008488A MX2009008488A MX2009008488A MX2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A MX 2009008488 A MX2009008488 A MX 2009008488A
- Authority
- MX
- Mexico
- Prior art keywords
- dosage form
- oral dosage
- picoplatin
- water
- core
- Prior art date
Links
- IIMIOEBMYPRQGU-UHFFFAOYSA-L picoplatin Chemical compound N.[Cl-].[Cl-].[Pt+2].CC1=CC=CC=N1 IIMIOEBMYPRQGU-UHFFFAOYSA-L 0.000 title abstract 4
- 229950005566 picoplatin Drugs 0.000 title abstract 4
- 239000006186 oral dosage form Substances 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88917107P | 2007-02-09 | 2007-02-09 | |
| US88968107P | 2007-02-13 | 2007-02-13 | |
| PCT/US2008/001752 WO2008097661A1 (en) | 2007-02-09 | 2008-02-08 | Stabilized picoplatin oral dosage form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009008488A true MX2009008488A (es) | 2010-01-15 |
Family
ID=39682046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009008488A MX2009008488A (es) | 2007-02-09 | 2008-02-08 | Forma estabilizadora de dosificacion oral de picoplatino. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2114418A4 (enExample) |
| JP (1) | JP2010518089A (enExample) |
| KR (1) | KR20090109129A (enExample) |
| CN (2) | CN101678046A (enExample) |
| AU (1) | AU2008214202A1 (enExample) |
| BR (1) | BRPI0806418A2 (enExample) |
| CA (1) | CA2677640A1 (enExample) |
| HK (1) | HK1206267A1 (enExample) |
| IL (1) | IL200262A0 (enExample) |
| MX (1) | MX2009008488A (enExample) |
| RU (1) | RU2009133446A (enExample) |
| WO (1) | WO2008097661A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8178564B2 (en) | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| WO2010120336A1 (en) * | 2009-04-15 | 2010-10-21 | Poniard Pharmaceuticals, Inc. | High bioavailability oral picoplatin anti-cancer therapy |
| WO2015179847A1 (en) * | 2014-05-23 | 2015-11-26 | Mingsight Pharmaceuticals, Inc. | Treatment of autoimmune disease |
| CN107778331B (zh) * | 2016-08-27 | 2020-06-30 | 鲁南制药集团股份有限公司 | 一种甲啶铂的提纯方法 |
| CN108864177B (zh) * | 2018-04-20 | 2020-07-28 | 公安部物证鉴定中心 | [2h3]-1-甲氨基-2-苯基丙烷的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9502799D0 (en) * | 1995-02-14 | 1995-04-05 | Johnson Matthey Plc | Improvements in platinum complexes |
| ATE348617T1 (de) * | 2000-02-16 | 2007-01-15 | Astellas Pharma Inc | Heilmittel gegen durch endothelin verursachte erkrankungen |
| US6939568B2 (en) * | 2001-04-23 | 2005-09-06 | Nucryst Pharmaceuticals Corp. | Treatment of inflammatory skin conditions |
| DE10141528B4 (de) * | 2001-08-24 | 2006-08-10 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung |
| AU2003220022A1 (en) * | 2002-03-01 | 2003-09-16 | Trustees Of Dartmouth College | Compositions and methods for preventing sporadic neoplasia in colon |
| WO2004006859A2 (en) * | 2002-07-16 | 2004-01-22 | Sonus Pharmaceuticals, Inc. | Platinum compound |
| CN1681478A (zh) * | 2002-08-02 | 2005-10-12 | 川塞夫有限公司 | 铂聚集体及其制备方法 |
| AU2005223654A1 (en) * | 2004-03-18 | 2005-09-29 | Transave, Inc. | Administration of cisplatin by inhalation |
| US20060205810A1 (en) * | 2004-11-24 | 2006-09-14 | Schering Corporation | Platinum therapeutic combinations |
-
2008
- 2008-02-08 CN CN200880011357A patent/CN101678046A/zh active Pending
- 2008-02-08 CN CN201410283507.2A patent/CN104288119A/zh active Pending
- 2008-02-08 WO PCT/US2008/001752 patent/WO2008097661A1/en not_active Ceased
- 2008-02-08 BR BRPI0806418-0A patent/BRPI0806418A2/pt not_active IP Right Cessation
- 2008-02-08 RU RU2009133446/15A patent/RU2009133446A/ru not_active Application Discontinuation
- 2008-02-08 KR KR1020097018780A patent/KR20090109129A/ko not_active Withdrawn
- 2008-02-08 EP EP08725393A patent/EP2114418A4/en not_active Withdrawn
- 2008-02-08 JP JP2009549128A patent/JP2010518089A/ja active Pending
- 2008-02-08 MX MX2009008488A patent/MX2009008488A/es not_active Application Discontinuation
- 2008-02-08 CA CA002677640A patent/CA2677640A1/en not_active Abandoned
- 2008-02-08 AU AU2008214202A patent/AU2008214202A1/en not_active Abandoned
-
2009
- 2009-08-06 IL IL200262A patent/IL200262A0/en unknown
-
2015
- 2015-07-21 HK HK15106959.9A patent/HK1206267A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104288119A (zh) | 2015-01-21 |
| EP2114418A1 (en) | 2009-11-11 |
| IL200262A0 (en) | 2010-04-29 |
| EP2114418A4 (en) | 2013-01-09 |
| RU2009133446A (ru) | 2011-03-20 |
| CN101678046A (zh) | 2010-03-24 |
| CA2677640A1 (en) | 2008-08-14 |
| AU2008214202A1 (en) | 2008-08-14 |
| WO2008097661A1 (en) | 2008-08-14 |
| KR20090109129A (ko) | 2009-10-19 |
| JP2010518089A (ja) | 2010-05-27 |
| BRPI0806418A2 (pt) | 2011-09-06 |
| HK1206267A1 (en) | 2016-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009008487A (es) | Picoplatino encapsulado. | |
| MX2011012196A (es) | Composiciones y metodos para el suministro de farmaco. | |
| MX2012000217A (es) | Sistema de suministro de farmacos que comprende polioxazolina y un agente bioactivo. | |
| MX2012006829A (es) | Formulaciones resistentes al abuso. | |
| MY173832A (en) | Sintering powder | |
| CL2017002549A1 (es) | Uso de una composición de bismuto-tiol (bt), que sirve para preparar un medicamento útil para el tratamiento de una herida abierta que tiene o que está en riesgo de tener una infección de biopelícula bacteriana. | |
| WO2010064126A3 (en) | Controlled release dosage forms | |
| SG170047A1 (en) | Nanoparticulate posaconazole formulations | |
| MX374014B (es) | Composiciones farmaceuticas para la entrega de farmacos insolubles en agua. | |
| EP1832289A3 (en) | Compositions and coatings for implantable medical devices | |
| EP3266812A3 (en) | Nano-coatings for articles | |
| WO2009040811A3 (en) | Polymer nanoparticles coated by magnetic metal oxide and uses thereof | |
| IN2014CN04825A (enExample) | ||
| MX2011011829A (es) | Composicion para suministro sostenido de farmaco que comprende un aglutinante geopolimerico. | |
| GEP20125420B (en) | Solid pharmaceutical composition comprising benzimidazole compound | |
| MY162656A (en) | Oral compositions containing microaggregates | |
| TW200806282A (en) | Solid dosage formulations | |
| PH12016500855A1 (en) | Pharmaceutical preparation and method of its production and use | |
| MX2021006550A (es) | Lubricante para metalurgia de polvos y composiciones de polvo metalico que contienen el lubricante. | |
| MX2012007997A (es) | Preparacion solida recubierta. | |
| PH12020550113A1 (en) | Solid simethicone particles and dosage form thereof | |
| GB2573710A (en) | Methods and treatment fluids for microfracture creation and microproppant delivery in subterranean formations | |
| WO2008099615A1 (ja) | 微粒子油性懸濁液を含む医薬組成物 | |
| MX2016001514A (es) | Agentes de sosten y aditivos anti-reflujo que incluyen arcilla de caolin. | |
| EP3391874A3 (en) | Delivery devices containing encapsulated and/or particle- bound active pharmaceutical ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |